Faculty
Oncology Division
Alphabetical list (active faculty):   
Miriam Y. Kim

Miriam Y. Kim, MD

Assistant Professor

Department of Medicine

Oncology Division

Bone Marrow Transplantation & Leukemia

Research Interests

  • CAR T cells
  • Immunotherapy
  • AML

Contact

  • 314-273-2402 (office)
  • Division of Oncology
    Mail Stop 8007-0057-06
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 11th Floor Mid-Campus Center (office)

Original Articles

  • CD7-Deleted Hematopoietic Stem Cells Can Restore Immunity After CAR T Cell Therapy
    Kim MY, Cooper ML, Jacobs MT, Ritchey JK, Hollaway J, Fehniger TA, DiPersio JF
    JCI Insight 2021 Aug 23;6(16):e149819
  • Prediction and Validation of Hematopoietic Stem and Progenitor Cell Off-Target Editing in Transplanted Rhesus Macaques
    AlJanahi AA, Lazzarotto CR, Chen S, Shin TH, Cordes S, Fan X, Jabara I, Zhou Y, Young DJ, Lee BC, Yu KR, Li Y, Toms B, Tunc I, Hong SG, Truitt LL, Klermund J, Andrieux G, Kim MY, Cathomen T, Gill S, Tsai SQ, Dunbar CE
    Mol Ther 2021 Jun 23; [Epub ahead of print]
  • CAR-Modified Memory-Like NK Cells Exhibit Potent Responses to NK-Resistant Lymphomas
    Gang M, Marin ND, Wong P, Neal CC, Marsala L, Foster M, Schappe T, Meng W, Tran J, Schaettler M, Davila M, Gao F, Cashen AF, Bartlett NL, Mehta-Shah N, Kahl BS, Kim MY, Cooper ML, DiPersio JF, Berrien-Elliott MM, Fehniger TA
    Blood 2020 Nov 12;136(20):2308-2318
  • Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy
    Klichinsky M, Ruella M, Shestova O, Lu XM, Best A, Zeeman M, Schmierer M, Gabrusiewicz K, Anderson NR, Petty NE, Cummins KD, Shen F, Shan X, Veliz K, Blouch K, Yashiro-Ohtani Y, Kenderian SS, Kim MY, O'Connor RS, Wallace SR, Kozlowski MS, Marchione DM, Shestov M, Garcia BA, June CH, Gill S
    Nat Biotechnol 2020 Aug;38(8):947-953
  • Unlabeled Competitor Antibody to Reduce Nonlinear Signal Spillover in Mass Cytometry
    Sekhri P, Kim MY, Behbehani GK
    Cytometry A 2019 Aug;95(8):898-909
  • Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
    Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, Morrissette JJD, Sekhri P, Lazzarotto CR, Calvo KR, Kuhns DB, Donahue RE, Behbehani GK, Tsai SQ, Dunbar CE, Gill S
    Cell 2018 May 31;173(6):1439-1453e19
  • EPHB4 Is a Therapeutic Target in AML and Promotes Leukemia Cell Survival Via AKT
    Merchant A, Jorapur A, McManus A, Liu R, Krasnoperov V, Chaudhry P, Singh M, Harton L, Agajanian M, Kim M, Triche T, Druker B, Tyner J, Gill P
    Blood Advances 2017;1:1635
  • Pharmacoeconomic Implications of Lenalidomide Maintenance Therapy in Multiple Myeloma
    Kim MY, Sposto R, Swaika A, Asano H, Alamgir A, Chanan-Khan A, Ailawadhi S
    Oncology 2014;87(4):224-31
  • Updates on the Treatment of Human Epidermal Growth Factor Receptor Type 2-Positive Breast Cancer
    Kim M, Agarwal S, Tripathy D
    Curr Opin Obstet Gynecol 2014 Feb;26(1):27-33
  • Major Non-ABO Incompatibility Caused by Anti-Jk(A) in a Patient Before Allogeneic Hematopoietic Stem Cell Transplantation
    Kim MY, Chaudhary P, Shulman IA, Pullarkat V
    Immunohematology 2013;29(1):11-4
  • Anemia of Chronic Kidney Disease in Diabetic Patients: Pathophysiologic Insights and Implications of Recent Clinical Trials
    Forte V, Kim M, Steuber G, Asad S, McFarlane SI
    In: Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications (Zimering M, ed), 2011